Allopurinol for Gout an Unlikely Contributor to Kidney Disease
New Study Raises Cardiovascular Questions about Febuxostat for Gout
Study Finds Newer Gout Drug Poses Risk to Heart Patients
FDA Approves Lesinurad + Allopurinol
FDA Approves Duzallo for Hyperuricemia in Patients with Uncontrolled Gout
Allopurinol Appears More Renoprotective than Febuxostat in Older Adults
New Findings on Rheumatic Drug Therapies among Patients with Ankylosing Spondylitis, Gout, SLE
Lesinurad with Allopurinol When Allopurinol Alone Is Insufficient
